Evidence map›Paper›PMID 39648521›Full record

ArticleFuture medicinal chemistry2024

Yousaf Khan, Rafaqat Hussain, Wajid Rehman, Shoaib Khan, Aneela Maalik, Tayyiaba Iqbal, Tariq Aziz, Muhammad Irfan Afridi, Metab Alharbi, Abdullah F Alasmari

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Mechanism of interaction betweenFood chemistry: X · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yousaf KhanDepartment of Chemistry, COMSATS University Islamabad, Islamabad, Pakistan.
Rafaqat HussainCollege of Biology, Hunan University Changsha, Hunan, China.
Wajid RehmanDepartment of Chemistry, Hazara University, Mansehra, Khyber Pakhtunkhwa, Pakistan.
Shoaib KhanDepartment of Chemistry, Abbottabad University of Science and Technology (AUST), Abbottabad, Pakistan.
Aneela MaalikDepartment of Chemistry, COMSATS University Islamabad, Islamabad, Pakistan.
Tayyiaba IqbalDepartment of Chemistry, Abbottabad University of Science and Technology (AUST), Abbottabad, Pakistan.
Tariq AzizLaboratory of Animal Health Food Hygiene and Quality, University of Loannina, Arta, Greece.
Muhammad Irfan AfridiCollege of Biology, Hunan University Changsha, Hunan, China.
Metab AlharbiDepartment of Pharmacology and Toxicology, College of Pharmacy King Saud University, Riyadh, Saudi Arabia.
Abdullah F AlasmariDepartment of Pharmacology and Toxicology, College of Pharmacy King Saud University, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsCurrent research work aims to synthesize hybrid compounds with a thiazole-thiazolidinone structure, as potent inhibitors of urease and α-glucosidase enzymes. MATERIALS AND

methodsThese compounds were characterize through RESULTS AND

conclusionCompounds-4 (IC

Indexed as

alpha-GlucosidasesEnzyme InhibitorsGlycoside Hydrolase InhibitorsMolecular Docking SimulationThiazolesThiazolidinesUreaseHumansMolecular StructureStructure-Activity Relationshipalpha-GlucosidasesEnzyme InhibitorsGlycoside Hydrolase InhibitorsThiazolesThiazolidinesUreasemolecular dockingSARThiazolethiazolidinoneureaseα-glucosidase

Identifiers

PMID39648521
PMCPMC11731264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.